- Home
- KPTI vs RMTI Comparison
KPTI vs RMTI Comparison
Compare KPTI & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPTI
- RMTI
- Stock Information
- Founded
- KPTI 2008
- RMTI 1994
- Country
- KPTI United States
- RMTI United States
- Employees
- KPTI N/A
- RMTI N/A
- Industry
- KPTI Biotechnology: Pharmaceutical Preparations
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- KPTI Health Care
- RMTI Health Care
- Exchange
- KPTI Nasdaq
- RMTI Nasdaq
- Market Cap
- KPTI 66.7M
- RMTI 71.1M
- IPO Year
- KPTI 2013
- RMTI 1998
- Fundamental
- Price
- KPTI $7.53
- RMTI $1.64
- Analyst Decision
- KPTI Strong Buy
- RMTI Strong Buy
- Analyst Count
- KPTI 5
- RMTI 2
- Target Price
- KPTI $61.00
- RMTI $6.00
- AVG Volume (30 Days)
- KPTI 144.0K
- RMTI 201.6K
- Earning Date
- KPTI 05-07-2025
- RMTI 03-20-2025
- Dividend Yield
- KPTI N/A
- RMTI N/A
- EPS Growth
- KPTI N/A
- RMTI N/A
- EPS
- KPTI N/A
- RMTI N/A
- Revenue
- KPTI $145,237,000.00
- RMTI $98,917,000.00
- Revenue This Year
- KPTI $4.37
- RMTI $22.58
- Revenue Next Year
- KPTI $19.07
- RMTI N/A
- P/E Ratio
- KPTI N/A
- RMTI N/A
- Revenue Growth
- KPTI N/A
- RMTI 22.37
- 52 Week Low
- KPTI $5.90
- RMTI $1.35
- 52 Week High
- KPTI $24.75
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- KPTI 43.25
- RMTI 41.26
- Support Level
- KPTI $5.90
- RMTI $1.49
- Resistance Level
- KPTI $8.45
- RMTI $1.74
- Average True Range (ATR)
- KPTI 1.06
- RMTI 0.11
- MACD
- KPTI -0.01
- RMTI 0.00
- Stochastic Oscillator
- KPTI 36.38
- RMTI 44.12
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.